PregTox: A Resource of Knowledge about Drug Fetal Toxicity

Biomed Res Int. 2022 Apr 16:2022:4284146. doi: 10.1155/2022/4284146. eCollection 2022.

Abstract

Background: It is of vital importance to determine the safety of drugs. Pregnant women, as a special group, need to evaluate the effects of drugs on pregnant women as well as the fetus. The use of drugs during pregnancy may be subject to fetal toxicity, thus affecting the development of the fetus or even leading to stillbirth. The U.S. Food and Drug Administration (FDA) issued a toxicity rating for drugs used during pregnancy in 1979. These toxicity ratings are denoted by the letters A, B, C, D, and X. However, the query of drug pregnancy category has yet to be well established as electronic service.

Results: Here, we presented PregTox, a publicly accessible resource for pregnancy category information of 1114 drugs. The PregTox database also included chemical structures, important physico-chemical properties, protein targets, and relevant signaling pathways. An advantage of the database is multiple search options which allow systematic analyses. In a case study, we demonstrated that a set of chemical descriptors could effectively discriminate high-risk drugs from others (area under ROC curve reached 0.81).

Conclusions: PregTox can serve as a unique drug safety data source for drug development and pharmacological research.

MeSH terms

  • Drug-Related Side Effects and Adverse Reactions*
  • Female
  • Fetus
  • Humans
  • Pharmaceutical Preparations
  • Pregnancy
  • Prenatal Care
  • Stillbirth

Substances

  • Pharmaceutical Preparations